India’s Sun Pharma Waves The White Flag On Taro
This article was originally published in PharmAsia News
Executive Summary
Sun said it will no longer try to acquire the remaining 39% of Israel’s Taro Pharmaceutical after Taro shareholders continued to hold out for a higher bid.